Research and research management
1-3-2019 – 1-9-2023 Vice-Rector of Research, Utrecht University; Chair of Open Science Programme Utrecht University.
2018 - Member of the International Advisory Board, Swiss National Science Foundation.
2018 - 2019 Member of the National Platform Open Science for the Federation of UMC’s.
2009 – 2019 Dean and Vice Chairman of the Executive Board, UMC Utrecht. Initiator of UMC Utrecht 3.0, launching this strategy in 2009 at UMC Utrecht with 6 strategic multidisciplinary themes in matrix driving for clinical and societal impact.
Published Wetenschap 3.0 through AUP, Amsterdam.
Collaborated with the Dean of Veterinary Medicine on Utrecht Life Sciences in 2010, setting up structural collaboration (research and graduate school) between all life sciences labs on Utrecht Science Campus, including the Hubrecht Institute and the Princess Maxima Center for Pediatric Oncology. ULS is led by the three deans (UMCU, Veterinary Sciences and Sciences).
Science 3.0: Real Science, Real Knowledge, Amsterdam University Press, 2012. Co-Initiator of the Science in Transition movement, which held its 1st Symposium at Royal Academy in October 2013.
Since 2013 Frank frequently talks about Science in Transition in The Netherlands: slideshow.
At the Reward Alliance meeting Edinburgh in Sept 2015, at the Stanford Metrics Biannual Meeting in November 2015.
Strategy Connecting U, UMC Utrecht, strategy 2015-2020, on clinical and academic leadership, science in transition/open science, impact and patient involvement.
A new research evaluation method was adopted, which rewards and incentivizes researchers to strive for impact, science for science and science for society, working within the context of the multidisciplinary programmes.
Establishing the regional health care network, Regional Utrecht Academic Oncology network.
January 2017 Metrics and Science in Transition workshop in Washington DC.
2006 – 2009 Chairman of the Board and Manager of Research and Education of DLA, UMC Utrecht.
2004 – 2006 Member of the Board of the Division of Laboratories and Pharmacy (DLA) UMCU and Manager of Research and Education at DLA. DLA consists of the departments of Medical Microbiology; Pathology; Immunology, Clinical Chemistry and Hematology and Pharmacy; in total approximately 850 FTEs.
2004 - 2009 Chairman of the UMCU Programme Infection and Immunity and Director of the I&I programme of the Graduate School for Life Sciences at the faculties of Medicine, Veterinary Medicine and Science, Utrecht University.
2004 - 2009 Professor of Immunology and Head of the Department of Immunology, UMC Utrecht
2001 – 2004 Director of Sanquin Research Division (190 FTEs), including the Business Unit Sanquin Reagents (50 FTEs), reporting to the Sanquin Board of Directors; yearly turnover of 27 M Euro.
1998 – 2004 Head of Clinical Immunology Lab 15 FTEs (3 senior staff; 5 PhD’s en 7 technicians.
1998 – 2001 Manager of the CLB Division of Research and Education. Full responsibility for an independent national R&D division with large project and patent portfolio employing 170 FTEs.
1996 – 2004 Professor, University of Amsterdam, Medical Faculty AMC, Immunology of AIDS (0,2 FTEs)
1994 – 2004 Project leader of the viro-immunology task force Ethiopian-Netherlands AIDS Research Project (ENARP) Addis Ababa, Ethiopia.
1992- 1996 Project leader of the EU Concerted Action 'Development of immunological progression markers in HIV infection' in the BIOMED programme.
1990- 1998 Head of the Clinical Viro-Immunology Department, CLB part of Division Research and Division Diagnostics The department expanded to 60 FTEs organized in 4 labs. Grants were obtained from NWO, Dutch Cancer Organisation/ Nederlandse Kanker Bestrijding (KWF), Kidney Foundation The Netherlands, AIDS Fund and EU Biomed.
1992 - 1998 Member of the Management team, Division Research and Education, CLB, Amsterdam.
1988- 1990 Research Coordinator of the Clinical viro-immunology Department, CLB, responsible for cellular diagnostics on immune deficiencies and AIDS.
1987 – 1992 Senior Fellow of the Royal Academy of Arts and Sciences (KNAW) "Pathogenesis of HIV infection".
1986 - 2008 Project Leader of Viro-Immunology, Amsterdam Cohort Studies (ACS), secretary of the Project Management Team.
1984 - 1998 Viral Safety Services: Established and managed a contract-research unit in CLB that provided service on viral safety studies of blood products that expanded to 7 FTEs.
1984 - 1986 Postdoc of Immunology and virology of the pathogenesis of AIDS in the context of the Amsterdam Cohort Studies, a collaboration of Municipal Health Service (GG&GD) (Prof Dr. Coutinho), Virology AMC (Prof. van der Noordaa and Prof Dr. Goudsmit) and Internal Medicine, AMC (Prof Lange and Prof Dr. Danner).
EDUCATION
1981 – 1984 PhD research at CLB, and the Lab for Exp and Clin Immunology, Medical Faculty UvA/AMC Functional and phenotypic characterization of human T-cell populations with novel monoclonal antibodies.
1979 - 1981 Military service
Immunological and biochemical studies of bacterial vaccines in the Unit Immunochemistry of the Netherlands Institute for Public Health (RIVM), Bilthoven in collaboration with AMOLF, Amsterdam (Dr Haverkamp and Prof Dr J. Kistemaker). Development of protein-conjugated Neisseria meningitidis type B and C polysaccharide vaccines.